Martin Bachmann to Melanoma
This is a "connection" page, showing publications Martin Bachmann has written about Melanoma.
Connection Strength
0.349
-
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine. Front Immunol. 2019; 10:1015.
Score: 0.349